EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Microbial predictors of sustained clinical remission following the Crohn’s disease exclusion diet in adults and microbiome shifts toward healthy pediatric controls

Rotem Sigall-Boneh, Sarah Organ, Mohammed Ghiboub iD, Henit Yanai iD, Lee Abramas, Nicolette Wierdsma, Charlotte M Verburgt iD, Wouter J de Jonge iD, Joep P M Derikx, James D Lewis iD, Hong Gu, Joseph Bielawski und 5 weitere

Crohn’s & Colitis 360 · 08.07.2026 · 8 (3)

DOI: 10.1093/crocol/otag071 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Crohn’s & Colitis 360, online erschienen am 02.07.2026. Verfasst von Rotem Sigall-Boneh und 16 weiteren Autor:innen. Beteiligte Einrichtung: PIBD Research Centre-Paediatric Gastroenterology and Nutrition Unit, Edith Wolfson Medical Centre, Holon, Israel. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Azrieli Foundation and Nestlé Health Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The Crohn’s disease (CD) exclusion diet (CDED) is an emerging dietary therapy for inducing remission in CD. However, data on its effects on gut microbiome in adults remain limited. This study investigated microbial responses to CDED in adults with mild-to-moderate CD and compared them with pediatric patients and healthy pediatric controls.

Methods

Microbiome data were analyzed from a randomized controlled trial (RCT) in adults (baseline, weeks 6, 12, 24) and a pediatric RCT (baseline, weeks 6, 12). Baseline microbial composition, diversity, and functional potential were compared between patients who achieved sustained clinical remission (SCR) at both weeks 12 and 24 and those who did-not. Functional profiling was performed using gene ortholog annotations, linear discriminant analysis, and metabolite inference.

Results

Baseline microbial and functional profiles differed between patients with and without SCR. SCR was associated with lower alpha diversity, higher relative abundances of Alistipes and Faecalibacterium, and increased flagellin gene expression. SCR was associated with enrichment of genes for redox balance, fatty acid metabolism, and DNA repair, while non-SCR showed elevated NAD biosynthesis, bacterial adhesion, and pro-inflammatory pathways. Haemophilus and Prevotella were negatively linked to SCR. Compositional and functional microbiome analyses revealed a microbiome shift during CDED-induced remission toward a profile more similar to healthy pediatric controls.

Conclusions

Before and during CDED, distinct baseline microbial and functional profiles were associated with SCR. These highlight the potential of the gut microbiome as a biomarker for identifying patients most likely to benefit from sustained effects of dietary therapy, supporting a more personalized approach to CD management.

Schlagwörter

Stichwörter der Autor:innen

Crohn’s diseasedietmicrobiome

Autor:innen und Institutionen

  • PIBD Research Centre-Paediatric Gastroenterology and Nutrition Unit, Edith Wolfson Medical Centre, Holon, Israel.
  • Tytgat Institute for Liver and Intestinal Research-Amsterdam Gastroenterology Endocrinology and Metabolism, University of Amsterdam, Amsterdam, The Netherlands.
  • Department of Mathematics and Statistics, Dalhousie University, Halifax, Canada.
  • Department of Paediatric Gastroenterology and Nutrition, Amsterdam University Medical Centres-Emma Children's Hospital, Amsterdam, The Netherlands.
  • Paediatric Surgery, Emma Children's Hospital-Amsterdam University Medical Centre, Amsterdam, The Netherlands.
  • IBD Centre-Division of Gastroenterology, Rabin Medical Centre, Petah Tikva, Israel.

ORCID-Profile: Mohammed Ghiboub, Henit Yanai, Charlotte M Verburgt, Wouter J de Jonge, James D Lewis, Nitsan Maharshak, Johan Van Limbergen

Förderung

  • Azrieli Foundation and Nestlé Health Science

Zitieren

APA

Sigall-Boneh, R., Organ, S., Ghiboub, M., Yanai, H., Abramas, L., Wierdsma, N., Verburgt, C. M., de Jonge, W. J., Derikx, J. P. M., Lewis, J. D., Gu, H., Bielawski, J., Maharshak, N., Dotan, I., Wine, E., Dunn, K., & Van Limbergen, J. (2026). Microbial predictors of sustained clinical remission following the Crohn’s disease exclusion diet in adults and microbiome shifts toward healthy pediatric controls. Crohn’s & Colitis 360, 8(3). https://doi.org/10.1093/crocol/otag071

Vancouver

Sigall-Boneh R, Organ S, Ghiboub M, Yanai H, Abramas L, Wierdsma N, et al. Microbial predictors of sustained clinical remission following the Crohn’s disease exclusion diet in adults and microbiome shifts toward healthy pediatric controls. Crohn’s & Colitis 360. 2026;8(3). doi:10.1093/crocol/otag071

BibTeX
@article{SigallBoneh2026,
  author = {Sigall-Boneh, Rotem and Organ, Sarah and Ghiboub, Mohammed and Yanai, Henit and Abramas, Lee and Wierdsma, Nicolette and Verburgt, Charlotte M and de Jonge, Wouter J and Derikx, Joep P M and Lewis, James D and Gu, Hong and Bielawski, Joseph and Maharshak, Nitsan and Dotan, Iris and Wine, Eytan and Dunn, Katherine and Van Limbergen, Johan},
  title = {Microbial predictors of sustained clinical remission following the Crohn’s disease exclusion diet in adults and microbiome shifts toward healthy pediatric controls},
  journal = {Crohn’s & Colitis 360},
  year = {2026},
  volume = {8},
  number = {3},
  doi = {10.1093/crocol/otag071}
}
Kostenlos starten →